Shanghai Leaddiscovery Pharmaceutical Co entered into an agreement to acquire 30% interest in Dongying Lida Medical Company Co., Ltd from Shandong Polymer Biochemicals Co., Ltd. (SZSE:002476) for RMB 13 million on April 21, 2022. The consideration will be paid in cash. Shanghai Leaddiscovery shall pay the initial payment of CNY 3.9 million to the Shandong Polymer Biochemicals' designated bank account within 3 working days after the "Equity Transfer Agreement" takes effect.

and the remaining purchase price, that is, the second installment price of CNY 9.1 million, will be paid to the Shandong Polymer account. The transaction is subject to the equity transfer agreement, The Lida Pharmaceutical Shareholders' Meeting has reviewed and approved the internal decision-making procedures for approving the transaction, The seller's board of directors and/or The general meeting of shareholders reviewed and approved the internal decision-making procedure for approving the transaction.